Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus

Nefrologia (Engl Ed). 2020 Nov-Dec;40(6):675-676. doi: 10.1016/j.nefro.2019.11.005. Epub 2020 Jan 11.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antiviral Agents / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Bone Neoplasms / diagnostic imaging
  • Bone Neoplasms / secondary
  • Carcinoma, Hepatocellular / diagnostic imaging
  • Carcinoma, Hepatocellular / etiology*
  • Carcinoma, Hepatocellular / secondary
  • Fatal Outcome
  • Female
  • Fluorenes / therapeutic use*
  • Hepacivirus
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Immunosuppression Therapy
  • Kidney Transplantation
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / etiology*
  • Male
  • Renal Insufficiency, Chronic / surgery
  • Ribavirin / therapeutic use*
  • Sofosbuvir / therapeutic use*
  • Transplant Recipients
  • alpha-Fetoproteins / analysis

Substances

  • Antiviral Agents
  • Benzimidazoles
  • Fluorenes
  • alpha-Fetoproteins
  • ledipasvir, sofosbuvir drug combination
  • Ribavirin
  • Sofosbuvir